Ziopharm Oncology reported $68.26M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US $ 6528M 1461M
AstraZeneca AZN:LN 5762M 567M
Baxter International BAX:US $ 2294M 657M
Biogen BIIB:US $ 1749.3M 512.1M
Bioline Rx BLRX:US $ 11.45M 1.54M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Corcept Therapeutics CORT:US $ 61.86M 15.76M
Curis CRIS:US $ 18.47M 21.55M
Eleven Biotherapeutics EBIO:US $ 169.79M 7.15M
Gilead Sciences GILD:US $ 4296M 1042M
GlaxoSmithKline GSK:LN 10967M 6693M
Immunogen IMGN:US $ 437.66M 41.09M
Intercept Pharmaceuticals ICPT:US $ 48.32M 36.39M
Intrexon XON:US $ 40.32M 2.6M
Johnson & Johnson JNJ:US $ 1579M 322M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Merk MRK:US $ 8556M 460M
Novartis NOVN:VX SF 13852M 1445M
Pfizer PFE:US $ 2470M 526M
Ptc Therapeutics PTCT:US $ 144.18M 45.54M
Regeneron Pharmaceuticals REGN:US $ 3345.7M 460.1M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Tg Therapeutics TGTX:US $ 185.68M 113.21M
Verastem VSTM:US $ 46.69M 25.44M
YTE INCY:US $ 2256.76M 199.32M
Ziopharm Oncology ZIOP:US $ 68.26M 7.8M